High Court Criticizes UOB for Inconsistent Legal Stances on Late Mortgage Payment Fees NTPC Reports 34 Rise in Q4 Net Profit to 10615 Crore Total Income Declines Pixel Launch Raises Questions Google Assistant AI Privacy Concerns May Impact Market Position Hong Kong Surpasses Switzerland to Become Worlds Top Offshore Wealth Hub US Consumer Prices Accelerate 38 in April Marking Highest Annual Gain Since May 2023 Growth Stock Correction Risks Highlight Potential Appeal of AntiBeta ETFs HCC Q1 2026 Earnings EPS Misses Estimates as Operating Costs Pressure Results Grupo Cibest CIB Q4 2025 Earnings Massive EPS Miss Triggers Unexpected Stock Rally Adaptive Biotechnologies ADPT Q1 2026 Earnings Narrower Loss Beats Consensus Shares Edge Lower PNTG Q1 2026 Earnings Earnings per Share Surpass Estimates Amid Mixed Market Response GETY Q1 2026 Earnings EPS Misses by Wide Margin Stock Gains on Strategic Momentum Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4 Spero Therapeutics SPRO Jumps 49 as Stock Approaches Key Resistance at 315 Sera Prognostics Surges 15 Key Resistance in Sight for SERA Assertio Holdings ASRT Holds Steady Near Resistance as Consolidation Continues Silgan Holdings SLGN Holds Steady Near 38 as Shares Consolidate Between Key Support and Resistance Brookfield Property Partners LP Preferred Stock BPYPN Holds Steady Near 14 Up 022 CCI Approves LFPLLed Consortiums Stake Acquisition in Restaurant Brands Asia Oxford Lane Capital Corp OXLCG Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short PLAYSTUDIOS MYPS Slips 2 as Stock Tests Key Support Near 044 GBX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Stock Gain Airship AI Holdings Inc AISP Q3 2025 Earnings Significant EPS Miss Amidst Lack of Revenue Disclosure CAVA Q1 2026 Earnings EPS Beat Surpasses Expectations Shares Rise Oscar Health OSCR Q1 2026 Earnings EPS Smashes Estimates by 71 Shares Gain Viking Holdings VIK Q1 2026 Earnings Surprise EPS Beat Highlights Operational Resilience CRIS Q1 2026 Earnings DevelopmentStage Biotech Posts WiderthanExpected Loss with No Revenue IR Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises 214